# Latency Antibiotics for Previable Rupture Of Membranes Trial

> **NCT06917157** · PHASE4 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Preterm Prelabor Rupture of Membranes (PPROM)

## Interventions

- **DRUG:** Administration of antibiotics prophylactically at the time of membrane rupture
- **DRUG:** Administration of antibiotics non-prophylactically at 22 weeks

## Key facts

- **NCT ID:** NCT06917157
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-05-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI has decided to end study due to changes in Texas law and no participants were enrolled
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917157, "Latency Antibiotics for Previable Rupture Of Membranes Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06917157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*